On July 13th, 2017, a workshop on the application of MCDA in Vietnam was organized by the Ministry of Health, the International Quality Generics Group (IQGx) and EuroCham. The workshop consisted of introduction of the concept and sharing of international best practice of using MCDA for OPP reimbursement decisions.
The potential application area and action plan for MCDA in Vietnam was also discussed with key 20 invited stakeholders involved in the healthcare decision making (pricing, reimbursement, formulary listing and drug procurement) of OPPs for Vietnam. Customized pre-reading material was developed and circulated among participants prior to the workshop.
“Following the discussion among representatives during the Conference, the MCDA framework is strongly recommended for adoption to support Vietnam Drug Decision Making, especially in the Drug Procurement (tender) process. Committee member finalization, criteria selection, criteria weighting and criteria scoring for tender decisions were proposed as the next step followed by a customized framework for manufacturers to present their products for consideration.”